Cerevel Therapeutics Holdings, Inc. (CERE) has a market capitalization of $8.19B and trades at $44.96. The 52-week range is 19.59-44.99.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -16.8, Earnings Per Share (EPS) of $-2.67.
The stock has a beta of 1.41, operates in the Healthcare sector.
